Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis
Mathieu Rappas, A. Ali, K.A. Bennett, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1528-1543
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Impact of GPCR Structures on Drug Discovery
Miles Congreve, Chris de Graaf, Nigel A. Swain, et al.
Cell (2020) Vol. 181, Iss. 1, pp. 81-91
Open Access | Times Cited: 299
Put a ring on it: application of small aliphatic rings in medicinal chemistry
Matthias R. Bauer, Paolo Di Fruscia, Simon C. C. Lucas, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 4, pp. 448-471
Open Access | Times Cited: 293
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
Accurate Prediction of GPCR Ligand Binding Affinity with Free Energy Perturbation
Francesca Deflorian, Laura Pérez‐Benito, Eelke B. Lenselink, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 11, pp. 5563-5579
Closed Access | Times Cited: 75
Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 1
Nicholas A. Meanwell, Olivier Loiseleur
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 36, pp. 10942-10971
Closed Access | Times Cited: 45
Structural basis of neuropeptide Y signaling through Y1 receptor
Chaehee Park, Jinuk Kim, Seung-Bum Ko, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist
Angela Glen, Roland W. Bürli, David G. Livermore, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 100, pp. 129629-129629
Open Access | Times Cited: 8
Cyclic tailor-made amino acids in the design of modern pharmaceuticals
Jiang Liu, Jianlin Han, Kunisuke Izawa, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112736-112736
Closed Access | Times Cited: 57
New drug approvals for 2022: Synthesis and clinical applications
Shuo Yuan, Dandan Shen, Rui Jia, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2352-2391
Closed Access | Times Cited: 18
Structure-based development of a subtype-selective orexin 1 receptor antagonist
Jan Hellmann, Matthäus Drabek, Jie Yin, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 30, pp. 18059-18067
Open Access | Times Cited: 46
Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 2
Nicholas A. Meanwell, Olivier Loiseleur
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 36, pp. 10972-11004
Closed Access | Times Cited: 27
Molecular mechanism of the wake-promoting agent TAK-925
Jie Yin, Yanyong Kang, Aaron P. McGrath, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1607-1667
Closed Access | Times Cited: 13
Mapping O- and N-Glycosylation in Transmembrane and Interface Regions of Proteins: Insights from a Database Search Study
Giorgiana Diana Carmen Anghelescu, Maria Mernea, Dan Mihăilescu
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 327-327
Open Access
Cryo-EM structure of an activated GPR4–Gs signaling complex
Yitong Ma, Yijie Wang, Mengyuan Tang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders
Christoph Boss, John Gatfield, Christine Brotschi, et al.
ChemMedChem (2020) Vol. 15, Iss. 23, pp. 2286-2305
Closed Access | Times Cited: 37
Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation
Morgan Thomas, N.M. O'Boyle, Andreas Bender, et al.
Journal of Cheminformatics (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 20
The Role of Allylic Strain for Conformational Control in Medicinal Chemistry
Hongtao Zhao, Jonas Brånalt, Matthew W. D. Perry, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 7730-7755
Closed Access | Times Cited: 12
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
Interaction modes of human orexin 2 receptor with selective and nonselective antagonists studied by NMR spectroscopy
Kayo Imamura, Ken‐ichi Akagi, Yohei Miyanoiri, et al.
Structure (2024) Vol. 32, Iss. 3, pp. 352-361.e5
Open Access | Times Cited: 2
Structure-guided discovery of orexin receptor-binding PET ligands
Katharina Distler, Simone Maschauer, Eduard Neu, et al.
(2024)
Open Access | Times Cited: 2
Structure-guided discovery of orexin receptor-binding PET ligands
Katharina Distler, Simone Maschauer, Eduard Neu, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 110, pp. 117823-117823
Open Access | Times Cited: 2
The role of metal ions in G protein‐coupled receptor signalling and drug discovery
Rongfeng Zou, Xueying Wang, Shu Li, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2021) Vol. 12, Iss. 2
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top